The search for the palmitoylethanolamide receptor.

Palmitoylethanolamide (PEA), the naturally occurring amide of ethanolamine and palmitic acid, is an endogenous lipid that modulates pain and inflammation. Although the anti-inflammatory effects of PEA were first characterized nearly 50 years ago, the identity of the receptor mediating these actions has long remained elusive. We recently identified the ligand-activated transcription factor, peroxisome proliferator-activated receptor-alpha (PPAR-alpha), as the receptor mediating the anti-inflammatory actions of this lipid amide. Here we outline the history of PEA, starting with its initial discovery in the 1950s, and discuss the pharmacological properties of this compound, particularly in regards to its ability to activate PPAR-alpha.

[1]  F. Benvenuti,et al.  [Activity of some derivatives of palmitoylethanolamide on carragenine-induced edema in the rat paw]. , 1968, Bollettino della Societa italiana di biologia sperimentale.

[2]  R. Pertwee,et al.  Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. , 2000, European journal of pharmacology.

[3]  K. Melmon,et al.  FATTY ACID AMIDES OF ETHANOLAMINE IN MAMMALIAN TISSUES. , 1965, The Journal of biological chemistry.

[4]  N. Ueda,et al.  Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide (*) , 1995, The Journal of Biological Chemistry.

[5]  B. Cravatt,et al.  The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400377-JLR200 , 2005, Journal of Lipid Research.

[6]  R. Capasso,et al.  Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice , 2001, British journal of pharmacology.

[7]  D. Piomelli,et al.  Anandamide Amidohydrolase Activity in Rat Brain Microsomes , 1995, The Journal of Biological Chemistry.

[8]  F. Perlík,et al.  Prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin®) in acute respiratory tract infections , 1974, European Journal of Clinical Pharmacology.

[9]  V. Lagente,et al.  Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. , 1998, Life sciences.

[10]  W. Farquhar-Smith,et al.  A Novel Neuroimmune Mechanism in Cannabinoid-mediated Attenuation of Nerve Growth Factor–induced Hyperalgesia , 2003, Anesthesiology.

[11]  S. Conti,et al.  Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo‐oxygenase systems , 2002, British journal of pharmacology.

[12]  K. Bölcskei,et al.  Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. , 2003, Life sciences.

[13]  L. Petrelli,et al.  N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. , 1996, European journal of pharmacology.

[14]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[15]  Dallas Jones,et al.  Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.

[16]  A. Buriani,et al.  The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. R. Compton,et al.  Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. , 1996, The Journal of pharmacology and experimental therapeutics.

[18]  T. Vanderah,et al.  Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors , 2003, Anesthesiology.

[19]  R. Capasso,et al.  Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies , 2005, Neuropharmacology.

[20]  W. Farquhar-Smith,et al.  Administration of Endocannabinoids Prevents a Referred Hyperalgesia Associated with Inflammation of the Urinary Bladder , 2001, Anesthesiology.

[21]  D. Piomelli,et al.  Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. , 2001, European journal of pharmacology.

[22]  T. Bisogno,et al.  Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems , 2002, Fundamental & clinical pharmacology.

[23]  B. Cravatt,et al.  Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. , 2002, The Journal of pharmacology and experimental therapeutics.

[24]  A. Buriani,et al.  Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. A. Stone,et al.  Electrolyte levels in normal and dystrophic muscle determined by neutron activation. , 1957, Lancet.

[26]  D. A. Long,et al.  Factor in arachis oil depressing sensitivity to tuberculin in B.C.G.-infected guineapigs. , 1956, Lancet.

[27]  D. Epps,et al.  N-Acylethanolamine accumulation in infarcted myocardium. , 1979, Biochemical and biophysical research communications.

[28]  D. Piomelli,et al.  Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). , 2004, The Journal of biological chemistry.

[29]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[30]  D. Parolaro,et al.  Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat , 2002, British journal of pharmacology.

[31]  D. Piomelli,et al.  Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPAR-α)* , 2004, Journal of Biological Chemistry.

[32]  H. Schmid,et al.  Properties of rat liver N-acylethanolamine amidohydrolase. , 1985, The Journal of biological chemistry.

[33]  D. Piomelli,et al.  Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain , 1997, The Journal of Neuroscience.

[34]  F. Perlík,et al.  Anti-inflammatory properties of N(2-hydroxyethyl) palmitamide. , 1971, Acta physiologica Academiae Scientiarum Hungaricae.

[35]  J. Auwerx,et al.  Topical Peroxisome Proliferator Activated Receptor-α Activators Reduce Inflammation in Irritant and Allergic Contact Dermatitis Models , 2002 .

[36]  R. Levi‐montalcini,et al.  A proposed autacoid mechanism controlling mastocyte behaviour , 2005, Agents and Actions.

[37]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[38]  B. Martin,et al.  Cannabis: pharmacology and toxicology in animals and humans. , 1996, Addiction.

[39]  A. Coburn,et al.  THE EFFECT OF EGG YOLK IN DIETS ON ANAPHYLACTIC ARTHRITIS (PASSIVE ARTHUS PHENOMENON) IN THE GUINEA PIG , 1954, The Journal of experimental medicine.

[40]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[41]  W. Campbell,et al.  Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. , 1995, Biochimica et biophysica acta.

[42]  T. Bisogno,et al.  Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes* , 1997, The Journal of Biological Chemistry.

[43]  S. Vandevoorde,et al.  Anticonvulsant Activity of N‐Palmitoylethanolamide, a Putative Endocannabinoid, in Mice , 2001, Epilepsia.

[44]  W. Wahli,et al.  The PPARalpha-leukotriene B4 pathway to inflammation control. , 1996, Nature.

[45]  S. Gaetani,et al.  Modulation of Meal Pattern in the Rat by the Anorexic Lipid Mediator Oleoylethanolamide , 2003, Neuropsychopharmacology.

[46]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[47]  A. Rice,et al.  The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain , 1998, Pain.

[48]  S. Gaetani,et al.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α , 2003, Nature.

[49]  D. Piomelli,et al.  Control of pain initiation by endogenous cannabinoids , 1998, Nature.

[50]  Z. Dong,et al.  Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells. , 2000, The Biochemical journal.

[51]  Stephen P. Mayfield,et al.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.

[52]  D. Piomelli,et al.  The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide , 2005, Molecular Pharmacology.

[53]  W. Wahli,et al.  The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.

[54]  K. Waku,et al.  Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor , 2000, The Journal of Biological Chemistry.

[55]  C. Fowler,et al.  The palmitoylethanolamide family: a new class of anti-inflammatory agents? , 2002, Current medicinal chemistry.

[56]  D. Cockayne,et al.  Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Gaetani,et al.  An anorexic lipid mediator regulated by feeding , 2001, Nature.

[58]  L. Petrocellis,et al.  Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. , 2001, The Biochemical journal.

[59]  P. C. Schmid,et al.  Catabolism of N‐Acylethanolamine Phospholipids by Dog Brain Preparations , 1984, Journal of neurochemistry.

[60]  Raymond C Stevens,et al.  Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling , 2002, Science.

[61]  J. Schwartz,et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.

[62]  K. Waku,et al.  Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. , 1998, Archives of biochemistry and biophysics.

[63]  L. Venance,et al.  Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP , 1996, The Journal of Neuroscience.

[64]  B. Cravatt,et al.  The enzymatic inactivation of the fatty acid amide class of signaling lipids. , 2002, Chemistry and physics of lipids.

[65]  L. Petrocellis,et al.  An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. , 1998, European journal of pharmacology.

[66]  P. C. Schmid,et al.  Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brain , 1995, FEBS letters.

[67]  T. Vanderah,et al.  CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? , 2003, Current opinion in pharmacology.

[68]  A. Finazzi-Agro’,et al.  Cannabimimetic Activity, Binding, and Degradation of Stearoylethanolamide within the Mouse Central Nervous System , 2002, Molecular and Cellular Neuroscience.

[69]  M. E. Corcoran,et al.  Selective Antiepileptic Effects of N‐Palmitoylethanolamide, a Putative Endocannabinoid , 2004, Epilepsia.

[70]  D. Lamontagne,et al.  Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart. , 2003, Life sciences.

[71]  J. Bruthans,et al.  Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials. , 1979, Journal of hygiene, epidemiology, microbiology, and immunology.

[72]  V. Di Marzo,et al.  The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic? , 1999, Current medicinal chemistry.

[73]  D. Greenberg,et al.  Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility , 2003, The Journal of Neuroscience.

[74]  H. Schmid,et al.  N-acylated glycerophospholipids and their derivatives. , 1990, Progress in lipid research.

[75]  H. Zoghbi,et al.  Bidirectional control of airway responsiveness by endogenous cannabinoids , 2000, Nature.

[76]  S. Gaetani,et al.  Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.

[77]  N. Ueda,et al.  Purification and Characterization of an Acid Amidase Selective for N-Palmitoylethanolamine, a Putative Endogenous Anti-inflammatory Substance* , 2001, The Journal of Biological Chemistry.

[78]  B. Staels,et al.  Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation , 2000, Inflammation Research.

[79]  C. Fowler,et al.  Characterization of palmitoylethanolamide transport in mouse Neuro‐2a neuroblastoma and rat RBL‐2H3 basophilic leukaemia cells: comparison with anandamide , 2001, British journal of pharmacology.

[80]  S. Schwab,et al.  Release of Fatty Acid Amides in a Patient With Hemispheric Stroke: A Microdialysis Study , 2002, Stroke.

[81]  F. Kuehl,et al.  THE IDENTIFICATION OF N-(2-HYDROXYETHYL)-PALMITAMIDE AS A NATURALLY OCCURRING ANTI-INFLAMMATORY AGENT , 1957 .

[82]  Alan Saghatelian,et al.  Functional disassociation of the central and peripheral fatty acid amide signaling systems. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[83]  C. Newton,et al.  Cannabinoids and the immune system. , 2001, Pain research & management.

[84]  M. Murakami,et al.  Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. , 2004, The Biochemical journal.

[85]  M. Fabris,et al.  Stearoylethanolamide exerts anorexic effects in mice via downregulation of liver stearoyl‐coenzyme A desaturase‐1 mRNA expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.